Projects

IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.

Keywords

Research group

Researcher

From date

To date

La inmunidad innata frente al VIH-1 como estrategia de curación de la infección

Project status

Ongoing

Start/End

2017

/

2019

Principal investigator

Bonaventura Clotet Sala

Financing entity

Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI16/00103
GIFT - The Gut Microbiome in HIV infection: from Microbial Function to Immune Therapeutics

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Roger Paredes

Financing entity

Grifols
Novel bispecific Trimerbody targeting human 4-1BB and Env for immunotherapy based HIV-1 curative therapeutics

Project status

Ongoing

Start/End

2020

/

2022

Principal investigator

Julia García Prado

Participating entities

IrsiCaixa, Hospital 12 de Octubre research institute
Modulación del sistema inmune innato en niños infectados por SARS-Cov2 (Cov2Child)

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Cecilia Cabrera Navarro

Strategic lines

Cancer

Emerging infectious diseases
Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV. ETI-CURE “La Caixa” Health Research HR20-00218

Project status

Ongoing

Start/End

2021

/

2024

Principal investigator

Julia García Prado

External researchers

Maria José Buzón

Participating entities

Irsicaixa / VHIR / Universidad Autónoma de Madrid

Financing entity

ETI-CURE “La Caixa” Health Research
Study of HIV-induced mechanisms of cell death in the lymphoid tissue in HIV+ individuals with varying levels of viral and/or immune control

Project status

Ongoing

Start/End

2016

/

2018

Principal investigator

Cecilia Cabrera Navarro

Participating entities

Germans Trias i Pujol Institute for Health Science Research, Germans Trias i Pujol University Hospital

Financing entity

Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI15/01053

The cause of viral immunopathogenesis in lymphoid tissue is unknown. We study cell death, activation and inflammation mechanisms in ex vivo cultures of lymphoid tissues, biopsied rectal tissue of HIV+ individuals and rhesus macaque lymphoid tissues.
Regulación de la respuesta inmune por células T CD4+ VIH-específicas

Project status

Ongoing

Start/End

2018

/

2021

Principal investigator

Alex Olvera van der Stoep

Financing entity

Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/01465
CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Julia García Prado

Financing entity

Grifols
Risk of vertical transmission of SARS-CoV-2 in mothers with active infection during delivery: the CoMBaT study (Covid19 Mother to Baby Transmission Study)

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Cecilia Cabrera Navarro

Strategic lines

Cancer

Emerging infectious diseases
Fostering prophylactic and therapeutic strategies to fight the SARS-CoV-2 pandemic

Project status

Ongoing

Start/End

2020

/

2022

Principal investigator

Bonaventura Clotet Sala

Julià Blanco Arbués

Jorge Carrillo Molina

Nuria Izquierdo Useros

External researchers

Joquim Segalés, Julia Vergara-Alert, Alfonso Valencia, Victor Guallard

Participating entities

Barcelona Supercomputing Center (BSC), Animal Health Research Center (IRTA-CReSA)

Financing entity

Grifols